Olympiad Research’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Olympiad Research’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-82,305	Closed	-$1.98M	–	341
2023 Q1	$1.98M	Buy	+82,305	New	+$1.03M	2.31%	10

Other funds holding PRVB

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Olympiad Research's PRVB Position: Q2 2023 in Review

Olympiad Research sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 82,305 shares — an estimated $1.98M sold.

Olympiad Research first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $1.98M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Olympiad Research reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Olympiad Research sold 82,305 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $1.98M.
Olympiad Research first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Olympiad Research's Provention Bio, Inc. Common Stock position peaked at $1.98M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Olympiad Research's 13F filing for Q2 2023, filed 25 Jul 2023.